Inovio Pharmaceuticals, Inc.
VACCINES HAVING AN ANTIGEN AND INTERLEUKIN-21 AS AN ADJUVANT
Last updated:
Abstract:
Disclosed herein is a vaccine comprising an antigen and IL-21. Also disclosed herein are methods for increasing an immune response in a subject. The methods may comprise administering the vaccine to the subject in need thereof.
Status:
Application
Type:
Utility
Filling date:
15 Apr 2021
Issue date:
5 Aug 2021